Sort
8,912 grants matching “sars cov 2”
Mechanism of Inhibition of Entry Inhibitors against SARS-CoVs
$111,994Di S Xia · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
DEVELOPMENT OF AN ELECTRONIC CARE PLAN FOR PERSONS WITH MULTIPLE CHRONIC CONDITIONS (E-CARE)
$111,971Evelyn Gallego · Emi Advisors Llc · N02 · FY2022 · HD
Deciphering the Double-Edged Role of IFITM3 during SARS-CoV-2 Infection
$111,969Alex Compton · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Small Molecule Screening to Identify Novel Sars-CoV-2 Therapeutics
$111,910Sara Cherry · University Of Pennsylvania · R01 · FY2020 · AI
The Link: A Collective, Place-Based Approach to Inspiring Missoula's Next-Generation Healthcare Work Force
$111,813Holly Truitt · City Of Missoula · R25 · FY2021 · GM
Routine Care during COVID-19 pandemic for Low-income Older Adults with Diabetes and Dementia
$111,149Laura Margaret Keohane · Vanderbilt University Medical Center · R01 · FY2021 · AG
Evaluation of iDMV-1.0: A Single Dose Self-Amplifying Vaccine for SARS-CoV-2
$110,871Devdoot Majumdar · University Of Vermont & St Agric College · P20 · FY2022 · GM
Administrative Core
$110,829Karen M Ridge · Northwestern University At Chicago · P01 · FY2022 · HL
Interactions of SARS-CoV-2 infection and genetic variation on the risk of cognitive decline and Alzheimerâs disease in Ancestral and Admixed Populations
$110,683Gabriel Alejandro De Erausquin · University Of Texas Hlth Science Center · U19 · FY2025 · AG
Targeted mRNA therapies treating ARDS
$110,623Zhengjie Zhou · University Of Chicago · K99 · FY2023 · HL
Targeted mRNA therapies treating ARDS
$110,623Zhengjie Zhou · University Of Chicago · K99 · FY2024 · HL
Building Capacity to Study the Intersection Between COVID-19 and HIV-Related Stigma among Adolescents in Western Kenya
$110,589William Thomas Story · University Of Iowa · R21 · FY2021 · TW
Role of Data Streams In Informing Infection Dynamics in Africa- INFORM Africa
$110,435Alash'le G. Abimiku · Institute Of Human Virology · U54 · FY2022 · TW
Non-parametric Bayesian Method Development
$109,950Matthew Wheeler · National Institute Of Environmental Health Sciences · ZIA · FY2021 · ES
Blocking Cationic Antimicrobial Peptide-Resistance in Pseudomonas aeruginosa
$109,875Laura C. Miller Conrad · San Jose State University · SC3 · FY2023 · GM
Blocking Cationic Antimicrobial Peptide-Resistance in Pseudomonas aeruginosa
$109,875Laura C. Miller Conrad · San Jose State University · SC3 · FY2024 · GM
Pre-existing cross-reactive antibodies to the SARS CoV-2 spike in sera from subjects in developing countries
$109,700James L Arthos · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Administrative Core
$109,624Karen M Ridge · Northwestern University At Chicago · P01 · FY2023 · HL
Immunity to SARS-CoV-2 After Natural Infection or Vaccination
$109,107Mark Connors · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
RAPID: Collaborative Research: Transforming passive protective face masks toward active capture and inactivation of coronavirus with nano-assisted surfactant modification
$109,100Tara Sabo-Attwood · University Of Florida · · FY2020 · ENG
Designing effective RNA therapies for oocyte maturation
$108,996Nehemiah Seth Alvarez · Eastern Virginia Medical School · R21 · FY2023 · HD
Systems Biology Approach to SARS-CoV-2 Infection in Individuals with known COVID-19 Contacts: A Prospective Cohort Study
$108,886Nicholas Scanlon · Emory University · K38 · FY2021 · AI
Interrogating inflammatory responses to SARS-CoV-2 infection in vivo
$108,792Katrin Mayer-Barber · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
The Effects of Prior Checkpoint Inhibitor (CPI) Therapy on Mouse Hepatitis Coronavirus Induced Pneumonia
$108,714Parizad Torabi-Parizi · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL
Regulation and Function of respiratory mucosal immunity post SARS-CoV-2 vaccination and infection
$108,273Jinyi Tang · University Of Virginia · K99 · FY2025 · AI